Zacks Investment Research on MSN
Cancer stocks to consider as oncology innovation accelerates
An updated edition of the August 26, 2026, article. The global oncology market is evolving rapidly, fueled by rising cancer incidence, aging populations and continued medical advances. According to ...
As part of the NSF X-Labs program, Ginkgo will offer NSF X-Labs teams its protein testing services, enabling researchers to rapidly express and characterize protein designs, including those generated ...
Cardano’s path to a new ADA all-time high by 2030 depends on CIP-0113 issuance, Fireblocks support and Leios, not headlines alone.
AstraZeneca announced Phase III HICKORY findings for investigational efzimfotase alfa in 124 treatment-naïve adolescents and adults with hypophosphatasia. At week 25, the primary ...
Pixclara is the only FDA-approved radiopharmaceutical imaging drug for glioma, indicated for adults and children over the age ...
NVIDIA’s RTX Spark launch gives Windows buyers a much bigger decision than choosing a screen size. A compact creator laptop, a pen-equipped convertible, and a ...
AWS Transform now enables migration of block storage data for NetApp Inc.’s (NASDAQ:NTAP) unified data storage operating ...
This article appears in the November 2026 print edition with the headline “Choose Your Overlord.” When you buy a book using a ...
Only one of these looks like a buy to me.
Market Hang's panel discusses what comes next after the bull market's four-year run, how gas prices are impacting EV demand, ...
Key TakeawaysOn Oct. 8, Goldman Sachs upgraded Palantir to Buy from Neutral with a $230 price target, 18% above Wednesday’s ...
The International and Global Growth Funds outperformed benchmarks despite a volatile third quarter. Read the full analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results